carboxyamido-triazole has been researched along with Disease Exacerbation in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, C; Fei, K; Guo, L; Ju, R; Li, J; Li, S; Ye, C; Zhang, D; Zhu, L | 1 |
| Dutcher, JP; Friedland, DM; Leon, L; Manola, J; Roth, B; Wilding, G | 1 |
1 trial(s) available for carboxyamido-triazole and Disease Exacerbation
| Article | Year |
|---|---|
Phase II study of carboxyamidotriazole in patients with advanced renal cell carcinoma refractory to immunotherapy: E4896, an Eastern Cooperative Oncology Group Study.
Topics: Adult; Aged; Antineoplastic Agents; Carcinoma, Renal Cell; Disease Progression; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Patient Selection; Time Factors; Treatment Outcome; Triazoles | 2005 |
1 other study(ies) available for carboxyamido-triazole and Disease Exacerbation
| Article | Year |
|---|---|
Metabolic Mechanisms and a Rational Combinational Application of Carboxyamidotriazole in Fighting Pancreatic Cancer Progression after Chemotherapy.
Topics: Animals; Antineoplastic Agents; Aspartic Acid; Cell Line, Tumor; Cell Proliferation; Cell Respiration; Deoxyglucose; Disease Progression; Drug Interactions; Female; Glycolysis; Humans; Intracellular Space; Mice; Mice, Inbred BALB C; Mitochondria; Pancreatic Neoplasms; Triazoles; Xenograft Model Antitumor Assays | 2018 |